BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 9094315)

  • 1. Phosphorylation and activation of B-Myb by cyclin A-Cdk2.
    Ziebold U; Bartsch O; Marais R; Ferrari S; Klempnauer KH
    Curr Biol; 1997 Apr; 7(4):253-60. PubMed ID: 9094315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
    Saville MK; Watson RJ
    Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb.
    Bartsch O; Horstmann S; Toprak K; Klempnauer KH; Ferrari S
    Eur J Biochem; 1999 Mar; 260(2):384-91. PubMed ID: 10095772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.
    Santilli G; Cervellera MN; Johnson TK; Lewis RE; Iacobelli S; Sala A
    Oncogene; 2001 Dec; 20(57):8167-74. PubMed ID: 11781832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
    Bessa M; Saville MK; Watson RJ
    Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.
    Xu M; Sheppard KA; Peng CY; Yee AS; Piwnica-Worms H
    Mol Cell Biol; 1994 Dec; 14(12):8420-31. PubMed ID: 7969176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF.
    Voit R; Hoffmann M; Grummt I
    EMBO J; 1999 Apr; 18(7):1891-9. PubMed ID: 10202152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
    Joaquin M; Watson RJ
    J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes.
    Kudoh T; Ishidate T; Moriyama M; Toyoshima K; Akiyama T
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4517-21. PubMed ID: 7753836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1, B-myb and selective members of cyclin/cdk subunits are targets for protein kinase C-mediated bimodal growth regulation in vascular endothelial cells.
    Zhou W; Takuwa N; Kumada M; Takuwa Y
    Biochem Biophys Res Commun; 1994 Feb; 199(1):191-8. PubMed ID: 8123011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function.
    Müller-Tidow C; Wang W; Idos GE; Diederichs S; Yang R; Readhead C; Berdel WE; Serve H; Saville M; Watson R; Koeffler HP
    Blood; 2001 Apr; 97(7):2091-7. PubMed ID: 11264176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors.
    Hara E; Hall M; Peters G
    EMBO J; 1997 Jan; 16(2):332-42. PubMed ID: 9029153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function of hybrid human-yeast cyclin-dependent kinases in Saccharomyces cerevisiae.
    Bitter GA
    Mol Gen Genet; 1998 Oct; 260(1):120-30. PubMed ID: 9829836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of E2F-1 by cyclin A-cdk2.
    Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin E-CDK2 is a regulator of p27Kip1.
    Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE
    Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.
    Li X; McDonnell DP
    Mol Cell Biol; 2002 Jun; 22(11):3663-73. PubMed ID: 11997503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-cycle regulation of B-Myb protein expression: specific phosphorylation during the S phase of the cell cycle.
    Robinson C; Light Y; Groves R; Mann D; Marias R; Watson R
    Oncogene; 1996 May; 12(9):1855-64. PubMed ID: 8649845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.